Risperidone
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Prescription second-generation (atypical) antipsychotic approved for schizophrenia, bipolar mania, and irritability associated with autistic disorder. One of the most widely studied atypical antipsychotics with strong evidence for efficacy. Carries a notable risk of hyperprolactinemia and dose-dependent extrapyramidal symptoms at higher doses. Available as a long-acting injectable. Dosage must be determined by your prescribing physician.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Prescription second-generation (atypical) antipsychotic approved for schizophrenia, bipolar mania, and irritability associated with autistic disorder. NutriStack rates the supporting evidence as strong. Common adult dosing is 1–8 mg daily (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: psychotic symptom reduction, bipolar mania treatment, irritability reduction in autism. 10 sources indexed (1995–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Potently antagonizes dopamine D2 and serotonin 5-HT2A receptors. Also has high affinity for alpha-1 and alpha-2 adrenergic and histamine H1 receptors. The active metabolite 9-hydroxyrisperidone (paliperidone) has similar receptor binding. High D2 affinity at higher doses increases the risk of EPS and prolactin elevation.
Dosing & protocol.
Can be taken with or without food. Risperdal Consta (LAI) given IM every 2 weeks requires 3-week overlap with oral supplementation at initiation.
Full safety detail.
Side effects
- Hyperprolactinemia (gynecomastia, galactorrhea, amenorrhea)
- Weight gain
- Sedation
- Extrapyramidal symptoms (dose-dependent)
- Orthostatic hypotension
- Dizziness
- Metabolic effects
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
2- 1Population Pharmacokinetics of Risperidone and Paliperidone in Schizophrenia: A Systematic ReviewPMIDCarrascosa-Arteaga A, Nalda-Molina R, Más-Serrano P et al. · Pharmaceuticals (Basel, Switzerland) · 2025
Carrascosa-Arteaga A, Nalda-Molina R, Más-Serrano P et al.. Population Pharmacokinetics of Risperidone and Paliperidone in Schizophrenia: A Systematic Review. Pharmaceuticals (Basel, Switzerland). 2025
- 2Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic reviewPMIDde Brabander E, Kleine Schaars K, van Amelsvoort T et al. · Journal of psychiatric research · 2024
de Brabander E, Kleine Schaars K, van Amelsvoort T et al.. Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic review. Journal of psychiatric research. 2024
Reviews & position papers
5- 3Risperidone In Situ Microparticles: A Review in SchizophreniaPMIDSyed YY · Drugs · 2025
Syed YY. Risperidone In Situ Microparticles: A Review in Schizophrenia. Drugs. 2025
- 4Risperidone ISM(®): review and update of its usefulness in all phases of schizophreniaPMIDMesser T, Bernardo M, Anta L et al. · Therapeutic advances in psychopharmacology · 2024
Messer T, Bernardo M, Anta L et al.. Risperidone ISM(®): review and update of its usefulness in all phases of schizophrenia. Therapeutic advances in psychopharmacology. 2024
- 5Risperidone: a review of its use in the treatment of bipolar maniaPMIDFenton C, Scott LJ · CNS drugs · 2005
Fenton C, Scott LJ. Risperidone: a review of its use in the treatment of bipolar mania. CNS drugs. 2005
- 6Risperidone: a reviewPMIDMöller HJ · Expert opinion on pharmacotherapy · 2005
Möller HJ. Risperidone: a review. Expert opinion on pharmacotherapy. 2005
- 7Risperidone: review and assessment of its role in the treatment of schizophreniaPMIDCardoni AA · The Annals of pharmacotherapy · 1995
Cardoni AA. Risperidone: review and assessment of its role in the treatment of schizophrenia. The Annals of pharmacotherapy. 1995
Reference material
3- 8Lieberman JA et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia (CATIE). N Engl J Med. 2005.Source linkedPMID
- 9McCracken JT et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002.Source linkedPMID
- 10Schneider-Thoma J et al. Comparative efficacy and tolerability of antidopaminergic and muscarinic antipsychotics for acute schizophrenia: a network meta-analysis of randomised controlled trials indexed in international English and Chinese databases. Lancet. 2026.Source linkedPMID
Common questions.
Quick answers about Risperidone, drawn from the data on this page.
What is Risperidone?
Prescription second-generation (atypical) antipsychotic approved for schizophrenia, bipolar mania, and irritability associated with autistic disorder. One of the most widely studied atypical antipsychotics with strong evidence for efficacy. Carries a notable risk of hyperprolactinemia and dose-dependent extrapyramidal symptoms at higher doses. Available as a long-acting injectable. Dosage must be determined by your prescribing physician.
What is Risperidone used for?
Commonly cited benefits of Risperidone include: Psychotic symptom reduction; Bipolar mania treatment; Irritability reduction in autism; Long-acting injectable option for adherence; Well-studied efficacy profile. NutriStack rates the overall evidence as strong.
What is a typical dose of Risperidone?
A typical adult dose of Risperidone is 1–8 mg daily (as prescribed by your physician). The commonly recommended form is Tablet, orally disintegrating tablet, oral solution, or long-acting injectable. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Risperidone?
Reported side effects include hyperprolactinemia (gynecomastia, galactorrhea, amenorrhea), weight gain, sedation, extrapyramidal symptoms (dose-dependent), orthostatic hypotension, dizziness. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Risperidone?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Risperidone in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.